Advisory Editor-in-Chief
Andrew S Day, University of Otago, New Zealand
Editor-in-Chief
Xinjian Li, State Key Laboratory of Epigenetic Regulation and Intervention, IBP，Chinese Academy of Sciences, China
Research Interests: Immunometabolism
Xingxiang Pu, Hunan Cancer Hospital: Changsha, China
Executive Editor
Chunwei Xu, Hangzhou Institute of Medicine , Chinese Academy of Sciences, China
Memberships and Leadership Roles
- Committee Member of the IASLC Rare Tumors Committee (2023-2025)
- Secretary-General of the Expert Committee for Lung Cancer in the Yangtze River Delta and Secretary-General of its Youth Committee
- Committee Member of the CSCO (Chinese Society of Clinical Oncology) Young Experts Committee
- Standing Committee Member of the CSCO Melanoma Expert Committee Youth Committee
- Committee Member of the CSCO Melanoma Expert Committee
- Committee Member and Secretary of the CSCO Expert Committee for Geriatric Tumor Prevention and Treatment
- Committee Member of the CACA (Chinese Anti-Cancer Association) Professional Committee for Public Science Education
- Member of the CSCO Melanoma Guideline Expert Group
Associate Editors
Hengrui Liu, University of Cambridge, UK
Shifu Chen, Gannan Medical University; HaploX Biotechnology, China
Editorial Board Members
Ke Wang, Jiangsu institute of nuclear medicine, China
Hong Zhu, Zhejiang University, China
Jinrong Zheng, The First Hospital of Hebei Medical University, China
Shuai Ren, Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, China
Jincheng Wang, Hokkaido University, Japan
Bhaskar Roy, Hangzhou Institute of Medicine (HIM), Chinese Academy of Science, China
Shaogui Wan, Gannan Medical University, China
Rui Dong, Children‘s Hospital of Fudan University, China
Fares Al-Shargie, Rutgers University, United States
Andee Dzulkarnaen Zakaria, Department of Surgery, School of Medical Sciences & USM Specialist Hospital, Universiti Sains Malaysia, Malaysia
Jones Gyamfi, Teesside University, United Kingdom
Zimu Wu, Monash University, Australia
Wu, Hao, institute of systemimmunology， Würzburg University, Germany
Wai Chin Chong, Children’s National Hospital, United States
Manmeet Rawat, Penn State College of Medicine, United States
Sheila Spada, Tumor immunology and Immunotherpy Unit, Regina Elena National Cancer Institute , Italy
MUSTAFA ŞAHİN, Ankara University,Türkiy
Hsien-Yuan Lane, China Medical University
Oleg V. Tcheremissine, Psychiatry and Behavioral Medicine, Wake Forest University, United States
Monjur Ahmed, Thomas Jefferson University , United States
Academic Editor Responsibilities
Our volunteer Academic Editors oversee the peer review process from beginning to end, taking responsibility for conducting an initial assessment based on the IOMJ publication criteria, finding and securing reviewers, evaluating their feedback, making editorial decisions, and communicating decisions to authors. Academic Editors play an active role in the community, and are highly engaged as representatives of IOMJ.
Interested in serving on the Editorial Board?
IOMJ welcomes volunteers to the Editorial Board who support our mission, values, and commitment to providing a high-quality experience for our authors. Editorial Board Criteria
Academic Editors for IOMJ…
- are active researchers
- have a strong publication record of 10 or more peer-reviewed articles or H-index>5
- have senior or corresponding authorship publications
If you are interested in serving as an Academic Editor, please complete this short form. The IOMJ Editorial Board Services team will be in touch as soon as we are able.